Valine
In clinical developmentAlso known as (2S)-2-Amino-3-methylbutanoic acid, (S)-Valine, 2-Amino-3-methylbutyric acid, Aminosyn 10%, Sulfite-Free+42 more
(2S)-2-Amino-3-methylbutanoic acid, (S)-Valine, 2-Amino-3-methylbutyric acid, Aminosyn 10%, Sulfite-Free, Aminosyn 3.5 % M, Sulfite Free, Aminosyn 8.5 % with Electrolytes, Sulfite-Free, Aminosyn 8.5%, Sulfite-Free, Aminosyn II 10 %, Aminosyn II 15%, Aminosyn II 8.5 % with Electrolytes, Sulfite-Free, Aminosyn II 8.5 %, Sulfite-Free, Aminosyn-HBC 7 %, Sulfite-Free, Aminosyn-PF 10 %, Sulfite-Free, Aminosyn-PF 7%, Branchamin, Clinisol 15, Freamine III 10, Hepatamine 8, Hepatasol, L-(+)-alpha-Aminoisovaleric acid, L-Valine, L-alpha-Amino-beta-methylbutyric acid, L-valin, Nephramine, Plenamine, PremaSol, ProSol, ProcalAmine 3, Travasol 10, Travasol 10%, Trophamine, Trophamine 10 %, Trophamine 6 %, Val, Clinimix 4.25/10, Clinimix 4.25/25, Clinimix 4.25/5, Clinimix 5/15, Clinimix 5/20, Clinimix 5/25, Clinimix E 2.75/5, Clinimix E 4.25/10, Clinimix E 4.25/5, Clinimix E 5/15, Clinimix E 5/20, Clinimix E 5/25.
Recent clinical, regulatory, research and industry developments relating to this drug.
Retraction Note: Human HDAC6 senses valine abundancy to regulate DNA damage
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes5
Journals, researchers & institutions
- The New England journal of medicine2
- Genome biology1
- The Journal of neuroscience : the official journal of the Society for Neuroscience1
- Califf RM2
- Leimberger JD2
- McMurray JJ2
- Pfeffer MA2
- Rouleau JL2
- Solomon SD2
- Velazquez EJ2
- Zelenkofske S2
- Brigham and Women's Hospital2
- College of Veterinary Medicine1
- Hubei Key Laboratory of Agricultural Bioinformatics1
- Key Laboratory of Development of Veterinary Diagnostic Products1
- National Key Laboratory of Agricultural Microbiology1
- Novogene Bioinformatics Institute1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 6 of the same disease areas as Valine in the shared literature.
Studied across 6 of the same disease areas as Valine in the shared literature.
Studied across the same disease area as Valine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials